Skip to main content
HR 1690 107th Congress House Foreign Trade and International Finance AIDS (Disease) Access to health care Civil actions and liability Commerce Credit insurance Developing countries Drug industry Drugs Economics and Public Finance Export credit Export finance Federally-guaranteed loans Finance and Financial Sector Government lending Health Human immunodeficiency viruses Intellectual property International Affairs Law

Export-Import Bank HIV/AIDS Medicine Access Promotion Act

Introduced: May 2, 2001 Introduced by: Waters, Maxine Democratic · California See on congress.gov
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 14, 2001
Referred to the Subcommittee on International Monetary Policy and Trade.
May 2, 2001
Referred to the House Committee on Financial Services.
May 2, 2001
Introduced in House
 Plain-English summary Congressional Research Service
Export-Import Bank HIV/AIDS Medicine Access Promotion Act - Amends the Export-Import Bank Act of 1945 to prohibit the Export-Import Bank of the United States from guaranteeing, insuring, or extending credit in connection with the export of any good or service by or to a restrictive company (or parent or any subsidiary) that: (1) is challenging the validity of a qualified HIV/AIDS access law or policy in a court of law; (2) is a complaining party with respect to the law or policy, pursuant to any provision of the Agreement on Trade-related Aspects of Intellectual Property Rights of the Uruguay Round Agreements Act, or any provision of any other international agreement relating to intellectual property rights; or (3) has made a formal complaint, which has not been withdrawn, to the United States Trade Representative about such law or policy. Defines "qualified HIV/AIDS access law or policy" as a law or government policy of a developing country with respect to intellectual property which has the effect of regulating the use of a pharmaceutical or technology that may be used in the treatment of human immunodeficiency virus (HIV) or acquired immune deficiency syndrome (AIDS), or an associated opportunistic disease, and which promotes access to the pharmaceutical or technology by the population of such country.
What's happening now May 14, 2001

Referred to the Subcommittee on International Monetary Policy and Trade.

 Committees of jurisdiction 2